Home

Naseem Zojwalla

CIK 1905871 · CHIEF MEDICAL OFFICER · last filed 2026-02-04

Naseem Zojwalla is a CHIEF MEDICAL OFFICER who has filed 21 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for OLMA, was dated Feb 4, 2026. Across all open-market trades the lifetime net is −$8.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.28M

Companies

1

Total Filings

21

Lifetime Open-Market Net

-$7.99M

Filer Profile

Reported Address
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO, CA 94107
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OLMA CHIEF MEDICAL OFFICER 146,815 $8.75 $1.28M -$7.99M 14 2026-02-04

Recent Filings

21 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-04 OLMA Grant (A) — $0 EDGAR
2025-12-23 OLMA Notice (144) −99,509 -$2.75M EDGAR
2025-12-23 OLMA Mixed −129,509 -$5.87M EDGAR
2025-12-22 OLMA Notice (144) −100,000 -$2.80M EDGAR
2025-12-19 OLMA Notice (144) −70,000 -$1.97M EDGAR
2025-03-03 OLMA Grant (A) — $0 EDGAR
2024-12-17 OLMA Exer (M) +14,000 $68.2K EDGAR
2024-12-11 OLMA Notice (144) −14,522 -$126.1K EDGAR
2024-12-11 OLMA Mixed +24,195 -$250.5K EDGAR
2024-12-10 OLMA Notice (144) −13,283 -$124.5K EDGAR
Showing 1–10 of 21
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.